Target intelligence / Profile preview

Signal transducer and activator of transcription 5B (STAT5B)

Target
STAT5B
Molecular classification
Transcription factor, Signal transduction molecule
01

Overview

Signal transducer and activator of transcription 5B (STAT5B) is a transcription factor and intracellular signaling molecule encoded by the STAT5B gene. It belongs to the STAT protein family, which transduces signals from cytokine and growth factor receptors to the nucleus, where it activates transcription of target genes. STAT5B is especially important for immune cell development, regulation of cell growth and apoptosis, and growth hormone signaling. Activation occurs via receptor-associated kinases, especially Janus kinases, which phosphorylate STAT5B, enabling dimer formation and nuclear translocation. STAT5B is implicated in several diseases, including cancers (notably leukemias), growth hormone insensitivity syndromes, and immune disorders. Therapeutically, the Jak-STAT pathway—including STAT5B—is targeted primarily by Janus kinase inhibitors for autoimmune and malignant conditions. Aberrant STAT5B activity can contribute to tumorigenesis, immune dysregulation, and allergic inflammation[1][2][4][6].

Other names
STAT5BSignal transducer and activator of transcription 5BGHISID2STAT5Transcription factor STAT5BLOC107984978
02

Mechanism of action

Inhibition of upstream Janus kinase (JAK) activity to prevent STAT5B phosphorylation Inhibition of dimerization and DNA binding

03

Biological functions

Signal transductionTranscriptional activationCell proliferationCell survivalImmune regulationApoptosisLymphocyte developmentHematopoiesisRegulation of growth hormone signaling
04

Disease associations

Cancer (e.g., leukemia, lymphomas, myeloproliferative neoplasms)Growth hormone insensitivity syndromeImmune dysregulationAutoimmunityAllergic inflammation
05

Safety considerations

Risk of immune suppression and infection with long-term Jak-STAT pathway inhibitionOff-target effects due to pathway overlap among STAT proteinsPotential for cytopenias and increased risk of malignancy
06

Interacting drugs

Jak inhibitors (e.g., ruxolitinib)
07

Biomarkers

Phosphorylated STAT5B (pSTAT5B)STAT5B mRNA expressionGrowth hormone response markers (IGF-I)

Beyond the preview

Go deeper on Signal transducer and activator of transcription 5B (STAT5B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal transducer and activator of transcription 5B (STAT5B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call